Who are syntocinon nasal spray's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Syntocinon (Oxytocin), Carbetocin infusion, Continuous Oxytocin, Carbetocin Short-infusion, Oxytocin 4 mIU/mL, Oxytocin (High dose).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/syntocinon-nasal-spray.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

syntocinon nasal spray — Competitive Intelligence Brief

syntocinon nasal spray (syntocinon nasal spray) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Oxytocin receptor agonist. Area: Obstetrics and Gynecology.

marketed Oxytocin receptor agonist Oxytocin receptor (OXTR) Obstetrics and Gynecology Small molecule Live · refreshed every 30 min

Target snapshot

syntocinon nasal spray (syntocinon nasal spray) — Rambam Health Care Campus. Syntocinon (oxytocin) nasal spray binds to oxytocin receptors to stimulate uterine contractions and promote milk letdown during lactation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
syntocinon nasal spray TARGET	syntocinon nasal spray	Rambam Health Care Campus	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Syntocinon (Oxytocin)	Syntocinon (Oxytocin)	KU Leuven	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Carbetocin infusion	Carbetocin infusion	Ciusss de L'Est de l'Île de Montréal	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Continuous Oxytocin	Continuous Oxytocin	Ain Shams Maternity Hospital	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Carbetocin Short-infusion	Carbetocin Short-infusion	University Hospital, Basel, Switzerland	marketed	Oxytocin receptor agonist	Oxytocin receptor
Oxytocin 4 mIU/mL	Oxytocin 4 mIU/mL	Assistance Publique - Hôpitaux de Paris	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Oxytocin (High dose)	Oxytocin (High dose)	The University of Texas Medical Branch, Galveston	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Oxytocin receptor agonist class)

Assistance Publique - Hôpitaux de Paris · 2 drugs in this class
Ciusss de L'Est de l'Île de Montréal · 2 drugs in this class
Stony Brook University · 2 drugs in this class
The University of Texas Medical Branch, Galveston · 1 drug in this class
University Hospital, Basel, Switzerland · 1 drug in this class
Ain Shams Maternity Hospital · 1 drug in this class
Weill Medical College of Cornell University · 1 drug in this class
KU Leuven · 1 drug in this class
Rambam Health Care Campus · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). syntocinon nasal spray — Competitive Intelligence Brief. https://druglandscape.com/ci/syntocinon-nasal-spray. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab